描述
达可替 Rtu 50毫克注射液是一种含有活性成分盐酸多柔比星的药物产品。多柔比星是一种蒽环类抗生素,因其强大的抗癌特性而广泛用于化疗。它通过干扰癌细胞的生长并减缓或阻止其增殖来发挥作用。达可替 Rtu 50毫克注射液适用于治疗多种类型的癌症,包括乳腺癌、肺癌、卵巢癌、膀胱癌、淋巴瘤和白血病。它由医疗专业人员静脉给药。重要的注意事项包括潜在的严重副作用,如心脏毒性、骨髓抑制和外渗。患者在治疗期间应由医生密切监测。将注射液在室温下储存,避光保存,请勿冷冻。

Rx (Prescription Medicine)
USD $ 65.00
达可替 Rtu 50毫克注射液是一种化疗药物,用于治疗多种类型的癌症。它由医疗专业人员静脉给药,并需要严密的医疗监督。
达可替 Rtu 50毫克注射液是一种含有活性成分盐酸多柔比星的药物产品。多柔比星是一种蒽环类抗生素,因其强大的抗癌特性而广泛用于化疗。它通过干扰癌细胞的生长并减缓或阻止其增殖来发挥作用。达可替 Rtu 50毫克注射液适用于治疗多种类型的癌症,包括乳腺癌、肺癌、卵巢癌、膀胱癌、淋巴瘤和白血病。它由医疗专业人员静脉给药。重要的注意事项包括潜在的严重副作用,如心脏毒性、骨髓抑制和外渗。患者在治疗期间应由医生密切监测。将注射液在室温下储存,避光保存,请勿冷冻。
| Medicine Form | |
|---|---|
| Rx Status | |
| Medicine Type | |
| Molecule | |
| Brand Name | |
| Strength |
其他品牌的 Oxaliplatin 50 Mg — 同一活性成分且强度相同,但来自不同制造商。
医学审核
Renu Meena, B.Pharm
Medical Content Writer
Renu Meena is an experienced Medical Content Writer with a strong foundation in pharmacy practice. She holds a Bachelor of Pharmacy (B.Pharm) degree from Rajasthan University of Health Sciences (RUHS), Jaipur, and is registered with the Rajasthan State Pharmacy Council (Reg. No. 55661). With 4+ years of experience across clinical pharmacy and medical content development, she creates evidence-based content for medicines, diseases, and patient education. Her work is shaped by a strong understanding of pharmacovigilance and regulatory standards, including ICH guidelines, GVP modules, ICD-10/11, and safety reporting requirements. Renu focuses on making complex medical information simple, accurate, and useful for readers while maintaining high quality and compliance.